These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26287823)

  • 21. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
    Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
    J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The apolipoprotein E epsilon 2 allele and decline in episodic memory.
    Wilson RS; Bienias JL; Berry-Kravis E; Evans DA; Bennett DA
    J Neurol Neurosurg Psychiatry; 2002 Dec; 73(6):672-7. PubMed ID: 12438469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein E genotype impact on memory and attention in older persons: the moderating role of personality phenotype.
    Chapman BP; Benedict RHB; Lin F; Roy S; Porteinsson A; Szigeti K; Federoff H; Mapstone M
    Int J Geriatr Psychiatry; 2018 Feb; 33(2):332-339. PubMed ID: 28612377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein epsilon4 and neuropsychological performance in Alzheimer's disease and vascular dementia.
    McGuinness B; Carson R; Barrett SL; Craig D; Passmore AP
    Neurosci Lett; 2010 Oct; 483(1):62-6. PubMed ID: 20678545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oestrogen replacement therapy may improve memory functioning in the absence of APOE epsilon4.
    Burkhardt MS; Foster JK; Laws SM; Baker LD; Craft S; Gandy SE; Stuckey BG; Clarnette R; Nolan D; Hewson-Bower B; Martins RN
    J Alzheimers Dis; 2004 Jun; 6(3):221-8. PubMed ID: 15201477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. APOE ε4, Alzheimer's disease pathology, cerebrovascular disease, and cognitive change over the years prior to death.
    Yu L; Boyle P; Schneider JA; Segawa E; Wilson RS; Leurgans S; Bennett DA
    Psychol Aging; 2013 Dec; 28(4):1015-23. PubMed ID: 23647000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropsychological function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.
    Bondi MW; Salmon DP; Galasko D; Thomas RG; Thal LJ
    Psychol Aging; 1999 Jun; 14(2):295-303. PubMed ID: 10403716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apolipoprotein E epsilon4 allele differently affects the patterns of neuropsychological presentation in early- and late-onset Alzheimer's disease patients.
    Marra C; Bizzarro A; Daniele A; De Luca L; Ferraccioli M; Valenza A; Brahe C; Tiziano FD; Gainotti G; Masullo C
    Dement Geriatr Cogn Disord; 2004; 18(2):125-31. PubMed ID: 15211066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of the apolipoprotein E and catechol-O-methyltransferase genes in prospective and retrospective memory traits.
    Dongés B; Haupt LM; Lea RA; Chan RC; Shum DH; Griffiths LR
    Gene; 2012 Sep; 506(1):135-40. PubMed ID: 22771913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A gene-brain-cognition pathway for the effect of an Alzheimer׳s risk gene on working memory in young adults.
    Stevens BW; DiBattista AM; William Rebeck G; Green AE
    Neuropsychologia; 2014 Aug; 61():143-9. PubMed ID: 24967550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Presence of the APOE epsilon4 allele modifies the relationship between type 2 diabetes and cognitive performance: the Maine-Syracuse Study.
    Dore GA; Elias MF; Robbins MA; Elias PK; Nagy Z
    Diabetologia; 2009 Dec; 52(12):2551-60. PubMed ID: 19693485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between APOE genotype and cerebral small-vessel disease: a longitudinal study.
    Luo X; Jiaerken Y; Yu X; Huang P; Qiu T; Jia Y; Li K; Xu X; Shen Z; Guan X; Zhou J; Zhang M; Adni FTADNI
    Oncotarget; 2017 Jul; 8(27):44477-44489. PubMed ID: 28574812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. No association between subjective memory complaints and apolipoprotein E genotype in cognitively intact elderly.
    Harwood DG; Barker WW; Ownby RL; Mullan M; Duara R
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1131-9. PubMed ID: 15526312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered PET functional brain responses in cognitively intact elderly persons at risk for Alzheimer disease (carriers of the epsilon4 allele).
    Scarmeas N; Habeck C; Anderson KE; Hilton J; Devanand DP; Pelton GH; Tabert MH; Flynn J; Park A; Ciappa A; Tycko B; Stern Y
    Am J Geriatr Psychiatry; 2004; 12(6):596-605. PubMed ID: 15545327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. APOE genotype modifies the association between central arterial stiffening and cognition in older adults.
    Cambronero FE; Liu D; Neal JE; Moore EE; Gifford KA; Terry JG; Nair S; Pechman KR; Osborn KE; Hohman TJ; Bell SP; Sweatt JD; Wang TJ; Beckman JA; Carr JJ; Jefferson AL
    Neurobiol Aging; 2018 Jul; 67():120-127. PubMed ID: 29656011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apolipoprotein E-ε4 deficiency and cognitive function in hepatitis C virus-infected patients.
    Wozniak MA; Lugo Iparraguirre LM; Dirks M; Deb-Chatterji M; Pflugrad H; Goldbecker A; Tryc AB; Worthmann H; Gess M; Crossey MM; Forton DM; Taylor-Robinson SD; Itzhaki RF; Weissenborn K
    J Viral Hepat; 2016 Jan; 23(1):39-46. PubMed ID: 26306786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Web-Based Intervention Effects on Mild Cognitive Impairment Based on Apolipoprotein E Genotype: Quasi-Experimental Study.
    Tsolaki AC; Tsolaki M; Pandria N; Lazarou E; Gkatzima O; Zilidou V; Karagianni M; Iakovidou-Kritsi Z; Kimiskidis VK; Bamidis PD
    J Med Internet Res; 2020 May; 22(5):e14617. PubMed ID: 32379048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Variations in the APOE allele or BDNF Val66Met polymorphism are not associated with changes in cognitive function following a tertiary education intervention in older adults: the Tasmanian Healthy Brain Project.
    Thow ME; Summers MJ; Summers JJ; Saunders NL; Vickers JC
    Neurobiol Aging; 2017 Jul; 55():175-176. PubMed ID: 28438485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.